Chronic Myelod Leukemia Registry at Asan Medical Center
NCT01761695 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-07-20
Summary
The investigators would like to propose a prospective longitudinal observational cohort study for patients who will be diagnosed and/or treated for chronic myeloid leukemia at Asan Medical Center, Seoul, Korea, to use the acquired data for fundamentals of other retrospective analysis.
Conditions
- Leukemia, Chronic Myeloid
- Myeloid Leukemia, Chronic, Accelerated Phase
- Myeloid Leukemia, Chronic, Chronic Phase
Interventions
- OTHER
-
Diagnosed as CML
All patients who will be enrolled in this prospective registry are confined to those who are diagnosed as chronic myeloid leukemia at Asan Medical Center, Seoul, Korea, from Jan 2013 till Dec 2047
Sponsors & Collaborators
-
Asan Medical Center
lead OTHER
Principal Investigators
-
Dae-Young Kim, MD · Assistant Professor
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
Countries
- South Korea
Study Locations
More Related Trials
-
Leukemic Stem Cell Detection for Chronic Myeloid Leukemia Patients With Major Molecular Response
NCT04104035 ·Status: UNKNOWN
-
A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)
NCT04079296 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients
NCT07250217 ·Status: RECRUITING ·Phase: NA
-
Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment
NCT03573596 ·Status: UNKNOWN ·Phase: PHASE2
-
Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
NCT01570465 ·Status: TERMINATED
-
Allogeneic SCT for CML, TKI Failure After TKI Failure
NCT02172365 ·Status: UNKNOWN
-
Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML
NCT01794169 ·Status: TERMINATED ·Phase: PHASE2
-
Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia
NCT00342316 ·Status: COMPLETED ·Phase: NA
-
Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in the First Complete Remission (CR1)
NCT01146977 ·Status: UNKNOWN ·Phase: PHASE2
-
Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients
NCT02042690 ·Status: COMPLETED ·Phase: PHASE3
-
Frequency and Risk Factors of Acute Myeloid Leukemia
NCT05787951 ·Status: UNKNOWN
-
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies
NCT05772559 ·Status: RECRUITING
-
TKI Discontinuation in CML Patients of China
NCT03251352 ·Status: UNKNOWN
-
Outcomes of Acute Myeloid Leukemia Patients
NCT04392310 ·Status: UNKNOWN
-
Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia
NCT00337519 ·Status: UNKNOWN ·Phase: PHASE2
-
Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients
NCT03090477 ·Status: COMPLETED ·Phase: NA
-
Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients
NCT00631059 ·Status: TERMINATED ·Phase: NA
-
Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL
NCT07059156 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation
NCT03121079 ·Status: WITHDRAWN ·Phase: NA
-
Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice
NCT02698124 ·Status: UNKNOWN
-
Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia
NCT02344966 ·Status: UNKNOWN
-
Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study
NCT06323590 ·Status: ACTIVE_NOT_RECRUITING
-
Endothelial Function, Arterial Stiffness and Components
NCT01439217 ·Status: COMPLETED
-
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia (2015)
NCT02428517 ·Status: TERMINATED
-
2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients
NCT02917720 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2